Diego Delgado
MD, MSc, FCCS, FACC
Dr. Diego Delgado graduated in Medicine from the Universidad del Salvador in Buenos Aires, Argentina. He completed his Internal Medicine and Cardiology training in Buenos Aires. He completed a research fellowship in cardiac transplantation at Rush Presbyterian St. Luke’s Medical Center in Chicago, U.S. Dr. Delgado completed a research/clinical fellowship in heart failure and transplantation at the Toronto General Hospital. He completed his Master’s in Clinical Epidemiology at the University of Toronto.
Dr. Delgado held the Reuben and Florence Fenwick Family Professorship in Heart Failure. He is Professor in the Division of Cardiology at the University Health Network. Dr. Delgado is the Past President of the Interamerican Society of Cardiology and past Chair of the Canadian Cardiac Transplant Group. He is the Site Medical Director. Dr. Delgado is currently the Site Director, Division of Cardiology, Toronto General Hospital. His interests are immunologic aspects of heart failure and transplantation, and cardio-oncology.
Nowell Fine
MD, SM, FRCPC, FACC, FCCS, FASE, FHFSA
Dr. Nowell Fine is a heart failure cardiologist and echocardiologist in Calgary (Alberta, Canada). He is an Associate Clinical Professor of Cardiac Sciences, Medicine, and Community Health Sciences at the Cumming School of Medicine, University of Calgary. He is the Director of the Clinical and Research/Core Echocardiography Laboratories and co-lead of the Heart Failure Research Program. Dr. Fine has a clinical and research interest in heart failure and infiltrative cardiomyopathies, particularly cardiac amyloidosis and Anderson-Fabry disease, and is Co-Director of the Amyloidosis Program of Calgary and the Cardiac Amyloidosis Clinic. He is the co-principal investigator for the Canadian Registry for Amyloidosis Research.
Margot Davis
MD, MSc, FRCPC
Margot Davis is an advanced heart failure and transplant cardiologist at St. Paul’s Hospital, a Clinical Associate Professor at the University of British Columbia, and Director of the UBC Cardiac Amyloidosis Clinic and the UBC Cardiology-Oncology Program. Her research is focused on cardiac amyloidosis, heart disease in cancer patients, and advanced heart failure. She is co-PI of the Canadian Registry for Amyloidosis Research, Vice President of the Canadian Heart Failure Society, and Western Regional Director of the Canadian Cardiovascular Society.
Maxime Tremblay-Gravel
MD, MSc, FRCPC
Dr. Maxime Tremblay-Gravel, clinician-scientist at the Montreal Heart Institute, holds a degree in adult cardiology from the University of Montreal and advanced training in heart failure, heart transplant, and echocardiography from Stanford University. His research interests focus on heart failure, primary cardiomyopathies, and their genetic determinants.
